View in EDS

Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.

Saved in:
Bibliographic Details
Title: Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.
Authors: Makaro, Adam1 (AUTHOR), Świerczyński, Mikołaj1 (AUTHOR), Pokora, Kacper1 (AUTHOR), Sarniak, Barbara1 (AUTHOR), Kordek, Radzisław2 (AUTHOR), Fichna, Jakub1 (AUTHOR), Salaga, Maciej1 (AUTHOR) salaga.maciej@gmail.com
Source: Inflammopharmacology. Feb2024, Vol. 32 Issue 1, p377-392. 16p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 175830895
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Makaro%2C+Adam%22">Makaro, Adam</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Świerczyński%2C+Mikołaj%22">Świerczyński, Mikołaj</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pokora%2C+Kacper%22">Pokora, Kacper</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sarniak%2C+Barbara%22">Sarniak, Barbara</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kordek%2C+Radzisław%22">Kordek, Radzisław</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fichna%2C+Jakub%22">Fichna, Jakub</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salaga%2C+Maciej%22">Salaga, Maciej</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> salaga.maciej@gmail.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Inflammopharmacology%22">Inflammopharmacology</searchLink>. Feb2024, Vol. 32 Issue 1, p377-392. 16p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175830895
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10787-023-01227-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 16
        StartPage: 377
    Titles:
      – TitleFull: Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Makaro, Adam
      – PersonEntity:
          Name:
            NameFull: Świerczyński, Mikołaj
      – PersonEntity:
          Name:
            NameFull: Pokora, Kacper
      – PersonEntity:
          Name:
            NameFull: Sarniak, Barbara
      – PersonEntity:
          Name:
            NameFull: Kordek, Radzisław
      – PersonEntity:
          Name:
            NameFull: Fichna, Jakub
      – PersonEntity:
          Name:
            NameFull: Salaga, Maciej
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09254692
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Inflammopharmacology
              Type: main
ResultId 1